Metraipolis › archive › dc_abe76c25f835

Cardiac Conduction Disorders in Melanoma Patients Treated with CTLA-4-Containing Versus PD-1-Only Immune Checkpoint Inhibitor Therapy: A Propensity… — Europe PMC PMID:42649921

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42649921
DOI
10.3390/cancers18162608
License (as archived)
solo-consultazione
Archived
2026-10-16T20:22:29.546Z
SHA-256 of the archived text
984c98f795f8cad4a89ef403f463bcc952b2e663527e75cf3c4b8dbd301d7eeb
Stable URL of this page
https://metraipolis.com/documento/dc_abe76c25f835

How to cite

Cardiac Conduction Disorders in Melanoma Patients Treated with CTLA-4-Containing Versus PD-1-Only Immune Checkpoint Inhibitor Therapy: A Propensity… — Europe PMC PMID:42649921 — Europe PMC (en), https://europepmc.org/article/MED/42649921 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_abe76c25f835 (Metraipolis archive dc_abe76c25f835, sha256 984c98f795f8cad4a89ef403f463bcc952b2e663527e75cf3c4b8dbd301d7eeb)
BibTeX
@misc{dcabe76c25f835,
  title = {Cardiac Conduction Disorders in Melanoma Patients Treated with CTLA-4-Containing Versus PD-1-Only Immune Checkpoint Inhibitor Therapy: A Propensity… — Europe PMC PMID:42649921},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42649921},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_abe76c25f835; sha256 984c98f795f8cad4a89ef403f463bcc952b2e663527e75cf3c4b8dbd301d7eeb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42649921. Agents can read the archived copy with the MCP tool read_document.